Renee P. Tannenbaum - 15 Sep 2022 Form 4 Insider Report for Cardiff Oncology, Inc. (CRDF)

Role
Director
Signature
/s/ Renee P Tannenbaum
Issuer symbol
CRDF
Transactions as of
15 Sep 2022
Net transactions value
+$17,168
Form type
4
Filing time
19 Sep 2022, 08:37:44 UTC
Previous filing
22 Mar 2022
Next filing
24 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRDF Common Stock Purchase $10,976 +6,400 $1.72 6,400 15 Sep 2022 Direct
transaction CRDF Common Stock Purchase $6,192 +3,600 +56% $1.72 10,000 15 Sep 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.